• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

High dosage of aripiprazole-induced dysphagia

Abstract

Background:

Dysphagia as a main manifestation of extrapyramidal symptoms is an uncommon adverse effect of second-generation antipsychotics.

Method:

We present a 54-year-old drug-naïve patient with schizophrenia, who developed dysphagia with aripiprazole 30 mg daily treatment.

Results:

This is the first case report on aripiprazole-induced dysphagia. We discuss the risk factors that led to dysphagia in this case.

Conclusion:

Aripiprazole-induced dysphagia is rare, and it is important to beaware that it does occur with high-dosage treatment. © 2011 by Wiley Periodicals, Inc. (Int J Eat Disord 2011;)

Posted in: Journal Article Abstracts on 05/03/2011 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice